English

Brighter Publishe s Q&A following Capital Markets Day held on 9 September 2021

Report this content

Brighter AB (publ) today announced that the company has published the Q&A from its recent Capital Markets Day, held on 9 September 2021, which can be accessed via the following link: https://brighter.se/questions/

On Thursday 9 September 2021, the company held a Capital Markets Day and provided the market with an update on the company’s operations in different markets and a general presentation about the company and its solutions from Christer Trägårdh, Chairman of the Board, Erik Lissner, acting CEO, Åsa Svedenheim, acting Head of Sales & Marketing, and Jonas Johansson, Head of Operations.

A replay of the event can be found on the Investor section of the company’s website under “Presentations” via the following link: https://brighter.se/investors/presentations/

Due to regulations and corporate policies, the company cannot comment or answer questions pertaining to the following topics:

  • Brighter does not currently share financial forecasts. In the company's quarterly reports, we report on the financial situation on an ongoing basis
  • Brighter, as a public company, cannot comment on ongoing discussions with customers regarding potential contracts or partners. This information will be communicated through regular channels in line with the EU Market Abuse Regulation
     
  • As a matter of corporate policy, we do not comment on rumors or speculations in the market
     
  • We cannot comment on employees or boards private decisions (to own shares in the company)
     
  • We cannot comment on that as it would give proprietary information to our competitors

For further information, please contact:

Investor Relations

IR@brighter.se

Certified Adviser

Brighter’s Certified Adviser is Eminova Fondkommission AB,

+46 (0)8 – 684 211 00, adviser@eminova.se, www.eminova.se

About Brighter AB (publ)

Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO-13485 certified. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.

For more information, please visit our website at https://brighter.se/

Documents & Links